Your browser doesn't support javascript.
loading
A proline deletion in IFNAR1 impairs IFN-signaling and underlies increased resistance to tuberculosis in humans.
Zhang, Guoliang; deWeerd, Nicole A; Stifter, Sebastian A; Liu, Lei; Zhou, Boping; Wang, Wenfei; Zhou, Yiping; Ying, Binwu; Hu, Xuejiao; Matthews, Antony Y; Ellis, Magda; Triccas, James A; Hertzog, Paul J; Britton, Warwick J; Chen, Xinchun; Feng, Carl G.
Afiliación
  • Zhang G; Guangdong Key Laboratory of Emerging Infectious Diseases, Shenzhen Third People's Hospital, Guangdong Medical University, 518112, Shenzhen, Guangdong, China.
  • deWeerd NA; Immunology and Host Defense Group, Department of Infectious Diseases and Immunology, Sydney Medical School, The University of Sydney, Sydney, NSW, 2006, Australia.
  • Stifter SA; Tuberculosis Research Program, Centenary Institute, Camperdown, NSW, 2050, Australia.
  • Liu L; Hudson Institute of Medical Research, Clayton, VIC, 3168, Australia.
  • Zhou B; Immunology and Host Defense Group, Department of Infectious Diseases and Immunology, Sydney Medical School, The University of Sydney, Sydney, NSW, 2006, Australia.
  • Wang W; Tuberculosis Research Program, Centenary Institute, Camperdown, NSW, 2050, Australia.
  • Zhou Y; Guangdong Key Laboratory of Emerging Infectious Diseases, Shenzhen Third People's Hospital, Guangdong Medical University, 518112, Shenzhen, Guangdong, China.
  • Ying B; Guangdong Key Laboratory of Emerging Infectious Diseases, Shenzhen Third People's Hospital, Guangdong Medical University, 518112, Shenzhen, Guangdong, China.
  • Hu X; Guangdong Key Laboratory of Emerging Infectious Diseases, Shenzhen Third People's Hospital, Guangdong Medical University, 518112, Shenzhen, Guangdong, China.
  • Matthews AY; Department of Respiratory Medicine, Shenzhen Futian Hospital, Sun Yet-sen University, 518033, Shenzhen, Guangdong, China.
  • Ellis M; Department of Laboratory Medicine, West China Hospital, Sichuan University, 610041, Chengdu, Sichuan, China.
  • Triccas JA; Department of Laboratory Medicine, West China Hospital, Sichuan University, 610041, Chengdu, Sichuan, China.
  • Hertzog PJ; Hudson Institute of Medical Research, Clayton, VIC, 3168, Australia.
  • Britton WJ; Tuberculosis Research Program, Centenary Institute, Camperdown, NSW, 2050, Australia.
  • Chen X; Tuberculosis Research Program, Centenary Institute, Camperdown, NSW, 2050, Australia.
  • Feng CG; Microbial Pathogenesis and Immunity Group, Department of Infectious Diseases and Immunology, Sydney Medical School, The University of Sydney, Sydney, NSW, 2006, Australia.
Nat Commun ; 9(1): 85, 2018 01 08.
Article en En | MEDLINE | ID: mdl-29311663
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tuberculosis Pulmonar / Interferón beta / Receptor de Interferón alfa y beta / Hepatitis B / Antígenos de Superficie de la Hepatitis B Límite: Animals / Humans País/Región como asunto: Asia Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2018 Tipo del documento: Article País de afiliación: China
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tuberculosis Pulmonar / Interferón beta / Receptor de Interferón alfa y beta / Hepatitis B / Antígenos de Superficie de la Hepatitis B Límite: Animals / Humans País/Región como asunto: Asia Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2018 Tipo del documento: Article País de afiliación: China